<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer</title>
	<atom:link href="http://www.xconomy.com/boston/2009/11/05/gloucester-pharma-wins-fda-approval-of-drug-for-rare-skin-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/11/05/gloucester-pharma-wins-fda-approval-of-drug-for-rare-skin-cancer/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Derm News Friday, November 6 &#171; Derm Report</title>
		<link>http://www.xconomy.com/boston/2009/11/05/gloucester-pharma-wins-fda-approval-of-drug-for-rare-skin-cancer/comment-page-1/#comment-90868</link>
		<dc:creator>Derm News Friday, November 6 &#171; Derm Report</dc:creator>
		<pubDate>Fri, 06 Nov 2009 12:53:24 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=49348#comment-90868</guid>
		<description>[...] Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer -Xconomy [...]</description>
		<content:encoded><![CDATA[<p>[...] Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer -Xconomy [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Club funds young Hucknall mum&#8217;s last holiday - Nottingham Evening Post &#124; The Skin Cancer Blog</title>
		<link>http://www.xconomy.com/boston/2009/11/05/gloucester-pharma-wins-fda-approval-of-drug-for-rare-skin-cancer/comment-page-1/#comment-90854</link>
		<dc:creator>Club funds young Hucknall mum&#8217;s last holiday - Nottingham Evening Post &#124; The Skin Cancer Blog</dc:creator>
		<pubDate>Fri, 06 Nov 2009 10:38:12 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=49348#comment-90854</guid>
		<description>[...] Gloucester Pharmaceuticals has won clearance to start selling its first cancer drug in the U.S. The Cambridge, MA-based biotech company said today it has gotten the green light from the FDA to start marketing its romidepsin treatment, under the brand Read on  [...]</description>
		<content:encoded><![CDATA[<p>[...] Gloucester Pharmaceuticals has won clearance to start selling its first cancer drug in the U.S. The Cambridge, MA-based biotech company said today it has gotten the green light from the FDA to start marketing its romidepsin treatment, under the brand Read on  [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

